Shouichi Tanaka1, Osamu Imataki2, Atsuo Kitaoka3, Shuji Fujioka1, Etsuyo Hanabusa3, Yumiko Ohbayashi4, Makiko Uemura2, Nobuo Arima5, Tetsuji Yamamoto6. 1. Department of Rehabilitation, Faculty of Medicine, Kagawa University, Kagawa, Japan. 2. Division of Hematology and Stem Cell Transplantation, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan. 3. Division of Clinical Nutrition, Faculty of Medicine, Kagawa University, Kagawa, Japan. 4. Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan. 5. Department of Orthopedic Surgery, Sanuki Municipal Hospital, Kagawa, Japan. 6. Department of Orthopedic Surgery, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. sanutetu@med.kagawa-u.ac.jp.
Abstract
PURPOSE: We conducted a retrospective study to evaluate the effect of rehabilitation on minimizing sarcopenia during hematopoietic stem cell transplantation (HSCT) therapy. METHODS: We developed a protocol to test for retention of physical function during HSCT. Muscle strength, muscle circumference, and muscle function before and after HSCT were measured. Consecutive patients with hematological malignancies who underwent HSCT treatment were recruited in this research. RESULTS: We included 34 patients (16 females, 18 males; median age, 51.5 years). Bodyweight significantly decreased after HSCT (p < 0.001). Nine females and three males had sarcopenia prior to allogeneic HSCT. After HSCT, bilateral hand grip strength and bilateral knee extensor strength decreased significantly. The total caloric intakes for pre-conditioning, during preparation regimen, and after transplant were 1709, 1024, and 1445 kcal, respectively, and were significantly attenuated in the post-transplant period. Serum albumin was significantly decreased in the final period. Conversely, C-reactive protein was slightly but significantly increased across the transplantation process. Multivariate regression analysis revealed that oral caloric intake after the transplantation period and sex were significantly related to muscle weakness (p = 0.033 and 0.036, respectively). CONCLUSIONS: Sarcopenia during HSCT was affected by oral caloric intake during the preparation regimen and after transplantation. Physical therapy in conjunction with nutritional therapy may help prevent weakness in HSCT recipients.
PURPOSE: We conducted a retrospective study to evaluate the effect of rehabilitation on minimizing sarcopenia during hematopoietic stem cell transplantation (HSCT) therapy. METHODS: We developed a protocol to test for retention of physical function during HSCT. Muscle strength, muscle circumference, and muscle function before and after HSCT were measured. Consecutive patients with hematological malignancies who underwent HSCT treatment were recruited in this research. RESULTS: We included 34 patients (16 females, 18 males; median age, 51.5 years). Bodyweight significantly decreased after HSCT (p < 0.001). Nine females and three males had sarcopenia prior to allogeneic HSCT. After HSCT, bilateral hand grip strength and bilateral knee extensor strength decreased significantly. The total caloric intakes for pre-conditioning, during preparation regimen, and after transplant were 1709, 1024, and 1445 kcal, respectively, and were significantly attenuated in the post-transplant period. Serum albumin was significantly decreased in the final period. Conversely, C-reactive protein was slightly but significantly increased across the transplantation process. Multivariate regression analysis revealed that oral caloric intake after the transplantation period and sex were significantly related to muscle weakness (p = 0.033 and 0.036, respectively). CONCLUSIONS:Sarcopenia during HSCT was affected by oral caloric intake during the preparation regimen and after transplantation. Physical therapy in conjunction with nutritional therapy may help prevent weakness in HSCT recipients.
Authors: Elizabeth Ann Coleman; Sharon Coon; Julie Hall-Barrow; Kathy Richards; David Gaylor; Beth Stewart Journal: Cancer Nurs Date: 2003-10 Impact factor: 2.592
Authors: J Inoue; R Ono; A Okamura; T Matsui; H Takekoshi; M Miwa; M Kurosaka; R Saura; T Shimada Journal: Transplant Proc Date: 2010-09 Impact factor: 1.066
Authors: H J Lee; B Oran; R M Saliba; D M Couriel; K Shin; P Massey; J Neumann; M de Lima; R Champlin; S Giralt Journal: Bone Marrow Transplant Date: 2006-07-03 Impact factor: 5.483
Authors: Kenneth Fearon; Florian Strasser; Stefan D Anker; Ingvar Bosaeus; Eduardo Bruera; Robin L Fainsinger; Aminah Jatoi; Charles Loprinzi; Neil MacDonald; Giovanni Mantovani; Mellar Davis; Maurizio Muscaritoli; Faith Ottery; Lukas Radbruch; Paula Ravasco; Declan Walsh; Andrew Wilcock; Stein Kaasa; Vickie E Baracos Journal: Lancet Oncol Date: 2011-02-04 Impact factor: 41.316
Authors: Inge E P M van Haren; Hans Timmerman; Carin M Potting; Nicole M A Blijlevens; J Bart Staal; Maria W G Nijhuis-van der Sanden Journal: Phys Ther Date: 2012-12-06
Authors: Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni Journal: Age Ageing Date: 2010-04-13 Impact factor: 10.668
Authors: Maxi Kramer; Pia Heussner; Philipp Y Herzberg; Holger Andree; Inken Hilgendorf; Malte Leithaeuser; Christian Junghanss; Mathias Freund; Daniel Wolff Journal: Support Care Cancer Date: 2012-11-01 Impact factor: 3.603
Authors: Richard J Lin; Laure Michaud; Stephanie M Lobaugh; Reiko Nakajima; Audrey Mauguen; Theresa A Elko; Josel D Ruiz; Molly A Maloy; Craig S Sauter; Parastoo B Dahi; Miguel-Angel Perales; Gunjan L Shah; Nerea Castillo Flores; Míriam Sanchez-Escamilla; Ana Alarcón Tomas; Lucrecia Yáñez San Segundo; Christina Cho; Ioannis Politikos; Soo Jung Kim; Beatriz Korc-Grodzicki; Sean M Devlin; Michael Scordo; Heiko Schöder; Sergio A Giralt; Paul A Hamlin Journal: Leuk Lymphoma Date: 2020-03-31